Experts in ToxicologyHomeHome
Home PageAbout UsContact UsToxicology SupportProduct SafetyToxicology TopicsOther ServicesDr. Richard A. Parent

Toxicology Notes and Literature

Marijuana References


  1. AU: Accordino M . Hart CL
    TI: Neuropsychological deficits in long‑term frequent cannabis users. SO: Neurology 2006;67(10):1902; author reply 1902 CD: CTX‑039576
  2.  AU: Agurell S . Halldin M . Lindgren JE . Ohlsson A . Widman M . Gillespie H . Hollister L TI: Pharmacokinetics and metabolism of delta 1‑tetrahydrocannabinol and other cannabinoids with emphasis on man. SO: Pharmacol Rev 1986;38(1):21‑43 CD: CTX‑039592
  3.  AU: Alt A . Reinhardt G TI: Positive cannabis results in urine and blood samples after consumption of hemp food products. SO: J Anal Toxicol 1998 Jan‑Feb;22(1):80‑81 CD: CTX‑021013
  4. AU: Ameri A TI: The effects of cannabinoids on the brain. SO: Prog Neurobiol 1999;58(4):315‑348 CD: CTX‑038527
  5.  AU: Baselt RC TI: Disposition of Toxic Drugs and Chemicals in Man.
    SO: In:  Disposition of Toxic Drugs and Chemicals in Man. Baselt, R. C. (ed). Chemical Toxicology Institute, Foster City, CA,
    813 (1999).
    CD: CTX‑039932
  6. AU: Baselt RC TI: Unusually high cannabanoid concentrations in urine. SO: J Anal Toxicol 1984;8:16a CD: CTX‑039067
  7.  AU: Bianchi V . Donzelli G TI: Rapid reversed‑phase high‑performance liquid chromatographic method for the assay of urinary 11‑nor‑delta 9‑tetrahydrocannabinol‑9‑carboxylic acid and confirmation of use of cannabis derivatives. SO: J Chromatogr B Biomed Appl 1996 Jan 12;675(1):162‑167 CD: CTX‑021029
  8.  AU: Blanc JA . Manneh VA . Ernst R . Berger DE . de Keczer SA . Chase C . Centofanti JM . DeLizza AJ TI: Adsorption losses from urine‑based cannabinoid calibrators during routine use. SO: Clin Chem 1993 Aug;39(8):1705‑1712 CD: CTX‑021025
  9. AU: Block RI . Farinpour R . Braverman K TI: Acute effects of marijuana on cognition: relationships to chronic effects and smoking techniques. SO: Pharmacol Biochem Behav 1992;43:907‑917 CD: CTX‑028712
  10. AU: Bolla KI . Brown K . Eldreth D . Tate K . Cadet JL TI: SO: CD:
    Dose‑related neurocognitive effects of marijuana use. Neurology 2002;59(9):1337‑1343 CTX‑039558
  11.  AU: Boufford JI . Richard MM
  12. TI: Marijuana: current federal law remains in effect. SO: Conn Med 1997 Apr;61(4):229‑230

  13.  AU: Brendler J . Liu RH TI: Initial test cutoff selection based on regression analysis of initial test apparent analyte result vs GC/MS test analyte result‑‑evaluation of two radioimmunoassay kits' test data. SO: Clin Chem 1997 Apr;43(4):688‑690 CD: CTX‑021020
  14. AU: Brunet B . Doucet C . Venisse N . Hauet T . Hebrard W . Papet Y . Mauco G . Mura P TI: Validation of Large White Pig as ananimal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
    SO: Forensic Sci Int 2006;161(2‑3):169‑174 CD: CTX‑039559
  15. AU: Centers for Disease Control (CDC) TI: Urine testing for detection of marijuana: an advisory. SO: Morb Mortal Wkly Rep 1983;32(36):469‑471 CD: CTX‑039299
  16. AU: Chait LD . Fischman MW . Schuster CR TI: Hangover effects the morning after marijuana smoking. SO: Drug Alcohol Dep 1985;15:229‑238 CD: CTX‑028710
  17.  AU: Chait LD . Perry JL TI: Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. SO: Psychopharmacology 1994 Jul;115(3):340‑349 CD: CTX‑021024
  18.  AU: Chait LD TI: Subjective and behavioral effects of marijuana the morning after smoking. SO: Psychopharmacology 1990;100:328‑333 CD: CTX‑028711
  19.  AU: Chang L . Yakupov R . Cloak C . Ernst T TI: Marijuana use is associated with a reorganized visual‑attention network and cerebellar hypoactivation. SO: Brain 2006;129(Pt 5):1096‑1112 CD: CTX‑039560
  20. AU: Chiang CW . Barnett G TI: SO: CD:
    Marijuana effect and delta‑9‑tetrahydrocannabinol plasma level. Clin Pharmacol Ther 1984;36(2):234‑238 CTX‑038526
  21. AU: Christophersen AS TI: Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. SO: J Anal Toxicol 1986;10(4):129‑131 CD: CTX‑039103
  22. AU: Cirimele V . Kintz P . Mangin P TI: Testing human hair for cannabis.
    SO: Forensic Sci Int 1995 Jan 5;70(1‑3):175‑182 CD: CTX‑021034
  23.  AU: Cirimele V . Sachs H . Kintz P . Mangin P
  24. TI: Testing human hair for Cannabis. III. rapid screening procedure for the simultaneous identification of delta 9‑tetrahydrocannabinol, cannabinol, and cannabidiol. SO: J Anal Toxicol 1996 Jan‑Feb;20(1):13‑16
  25. AU: Cocchetto DM . Owens SM . Perez‑Reyes M . DiGuiseppi S . Miller LL TI: Relationship between plasma delta‑9‑tetrahydrocannabinol concentration and pharmacologic effects in man. SO: Psychopharmacology 1981;75(2):158‑164 CD: CTX‑039561
  26. AU: Collins M . Easson J . Hansen G . Hodda A . Lewis K TI: GC‑MS‑MS confirmation of unusually high delta 9‑tetrahydrocannabinol levels in two postmortem blood samples. SO: J Anal Toxicol 1997 Nov‑Dec;21(7):538‑542 CD: CTX‑021018
  27.  AU: Cone EJ . Johnson RE TI: Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. SO: Clin Pharmacol Ther 1986 Sep;40(3):247‑256 CD: CTX‑020968
  28. AU: Cone EJ . Lange R . Darwin WD TI: In vivo adulteration: excess fluid ingestion causes false‑negative marijuana and cocaine urine test results. SO: J Anal Toxicol 1998 Oct;22(6):460‑473 CD: CTX‑020949
  29. AU: Cone EJ . Huestis MA . Mitchell JM TI: Do consecutive urine catches differ in marijuana metabolite concentration? SO: J Anal Toxicol 1993 May‑Jun;17(3):186‑187 CD: CTX‑020958
  30.  AU: Cone EJ . Johnson RE . Paul BD . Mell LD . Mitchell J TI: Marijuana‑laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion. SO: J Anal Toxicol 1988 Jul‑Aug;12(4):169‑175 CD: CTX‑020965
  31.  AU: Cone EJ . Johnson RE . Darwin WD . Yousefnejad D . Mell LD . Paul BD . Mitchell J TI: Passive inhalation of marijuana smoke: urinalysis and room air levels of delta‑9‑tetrahydrocannabinol. SO: J Anal Toxicol 1987 May‑Jun;11(3):89‑96 CD: CTX‑020966
  32. AU: Cone EJ TI: Marijuana effects and urinalysis after passive inhalation and oral ingestion. SO: NIDA Res Monogr 1990;99:88‑96 CD: CTX‑020964
  33. AU: Cone EJ . Roache JD . Johnson RE TI: Effects of passive exposure to marijuana smoke. SO: NIDA Res Monogr 1987;76:150‑156 CD: CTX‑020967
  34.  AU: Cone EJ . Johnson RE . Moore JD . Roache JD TI: Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. SO: Pharmacol Biochem Behav 1986 Jun;24(6):1749‑1754 CD: CTX‑020969
  35.  AU: Cone EJ . Huestis MA TI: Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.
    SO: Ther Drug Monit 1993 Dec;15(6):527‑532 CD: CTX‑020956
  36. AU: Cone EJ
  37. TI: Recent discoveries in pharmacokinetics of drugs of abuse. SO: Toxicol Lett 1998 Dec 28;102‑103:97‑101
  38. AU: Crouch DJ . Cheever ML . Andrenyak DM . Kuntz DJ . Loughmiller DL TI: A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results. SO: J Forensic Sci 1998 Jan;43(1):35‑40 CD: CTX‑021016
  39. AU: Drummer OH . Gerostamoulos J . Batziris H . Chu M . Caplehorn J . Robertson MD . Swann P TI: The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. SO: Accid Anal Prev 2004;36(2):239‑248 CD: CTX‑040210
  40. AU: Dugan S . Bogema S . Schwartz RW . Lappas NT TI: Stability of drugs of abuse in urine samples stored at ‑20 degrees C. SO: J Anal Toxicol 1994;18(7):391‑396 CD: CTX‑039101
  41. AU: Dunn EB . Wolfe JJ TI: Finding an optimal dose: considerations in accurate opoid dispensing. SO: Vet Hum Toxicol 2000;42(1):36‑38 CD: CTX‑032520
  42.  AU: ElSohly MA . Feng S . Murphy TP . Ross SA . Nimrod A . Mehmedic Z . Fortner N TI: Delta 9‑tetrahydrocannabivarin (delta 9‑THCV) as a marker for the ingestion of cannabis versus Marinol. SO: J Anal Toxicol 1999 May‑Jun;23(3):222‑224 CD: CTX‑021006
  43. AU: ElSohly MA . Jones AB TI: Drug testing in the workplace:  could a positive test for one of the mandated drugs be for reasons otherthan illicit use of the drug?
    SO: J Anal Toxicol 1995;19(6):450‑458 CD: CTX‑039562
  44.  AU: Falck R TI: Passive inhalation of marijuana smoke. SO: J Am Med Assoc 1983;250(7):898 CD: CTX‑039563
  45. AU: Fant RV . Heishman SJ . Bunker EB . Pickworth WB TI: Acute and residual effects of marijuana in humans. SO: Pharmacol Biochem Behav 1998 Aug;60(4):777‑784 CD: CTX‑02101
  46.  AU: Fraser AD . Coffin L . Worth D TI: Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses. SO: Clin Biochem 2002;35(7):501‑511 CD: CTX‑039097
  47. AU: Fraser AD . Worth D TI: Urinary excretion profiles of 11‑nor‑9‑carboxy‑delta9‑tetrahydrocannabinol and 11‑hydroxy‑delta9‑THC: cannabinoid metabolites to creatinine ratio study IV. SO: Forensic Sci Int 2004;143(2‑3):147‑152 CD: CTX‑039056
  48. AU: Fraser AD . Worth D TI: Urinary excretion profiles of 11‑nor‑9‑carboxy‑Delta9‑tetrahydrocannabinol. Study III. A Delta9‑THC‑COOH to creatinine ratio study.
    SO: Forensic Sci Int 2003;137(2‑3):196‑202
  49.  AU: Fraser AD . Worth D TI: Urinary excretion profiles of 11‑nor‑9‑carboxy‑Delta9‑tetrahydrocannabinol: a Delta9‑THC‑COOH to creatinine ratio study #2.
    SO: Forensic Sci Int 2003;133(1‑2):26‑31 CD: CTX‑039058
  50.  AU: Fraser AD TI: A 6‑year experience with urine drug testing by family service agencies in Nova Scotia, Canada. SO: Forensic Sci Int 2001;121(3):151‑156 CD: CTX‑039590
  51. AU: Fraser AD . Worth D TI: Urinary excretion profiles of 11‑nor‑9‑carboxy‑delta9‑tetrahydrocannabinol: a delta9‑THCCOOH to creatinine ratio study. SO: J Anal Toxicol 1999;23(6):531‑534 CD: CTX‑039591
  52. AU: Giardino NJ TI: An indoor air quality‑pharmacokinetic simulation of passive inhalation of marijuana smoke and the resultant buildup of 11‑nor‑delta‑9‑tetrahydrocannabinol‑9‑carboxylic acid in urine. SO: J Forensic Sci 1997 Mar;42(2):323‑325 CD: CTX‑021027
  53. AU: Giroud C . Menetrey A . Augsburger M . Buclin T . Sanchez‑Mazas P . Mangin P TI: Delta(9)‑THC, 11‑OH‑Delta(9)‑THC and Delta(9)‑THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. SO: Forensic Sci Int 2001;123(2‑3):159‑164 CD: CTX‑040209


In This Section

Causation Reports

Toxicology Notes and Literature

Toxicology Litigation Support